ePoster

LOSS OF DJ-1 AND PARKIN IN PARKINSON’S DISEASE OLIGODENDROCYTES INDUCES OXIDATIVE STRESS AND IMPAIRS DIFFERENTIATION AND MYELINATION

Jose Maria Salazar Camposand 3 co-authors

Biomedical Center (BMC), Faculty of Medicine, LMU Munich

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS03-08AM-064

Presentation

Date TBA

Board: PS03-08AM-064

Poster preview

LOSS OF DJ-1 AND PARKIN IN PARKINSON’S DISEASE OLIGODENDROCYTES INDUCES OXIDATIVE STRESS AND IMPAIRS DIFFERENTIATION AND MYELINATION poster preview

Event Information

Poster Board

PS03-08AM-064

Abstract

Parkinson’s disease (PD) has traditionally been viewed as a purely neuronal disorder, primarily characterized by degeneration of dopaminergic neurons in the substantia nigra. Growing evidence now indicates that glial cells, particularly oligodendrocytes (OLs), also contribute critically to PD pathogenesis. Recent studies have identified PD risk factors linked not only to dopaminergic neurons but also to OLs. Yet it remains unclear how OL-specific mechanistic pathways differ between PD and healthy brains, and which OL functions and cellular pathways contribute to midbrain neuron vulnerability.
To explore a potential causal role for OLs in PD aetiology, we generated PD patient-derived and CRISPR-engineered OLs from induced pluripotent stem cells (iPSCs) with loss of the PD-linked genes DJ-1 or parkin. In these cells, we uncovered reduced differentiation into both early and mature OLs, accompanied by oxidative stress and mitochondrial dysfunction, which was reversible upon correction of the DJ-1 mutation. Analysis of PD patient brain tissue confirmed decreased myelination, and transplantation of DJ-1-deficient OLs into ex vivo mouse brain slices likewise resulted in impaired myelination capacity. Collectively, our study shows how PD-associated mutations compromise OL functionality by affecting maturation, cellular stress responses, and myelin formation. These findings highlight a critical contribution of OLs to PD pathology, and suggest that restoring OL function may offer new therapeutic avenues for PD.

Recommended posters

STIMULATION OF OLIGODENDROGENESIS WITH THE SMALL MOLECULE WAY-316606 IN A MOUSE MODEL FOR PARKINSON’S DISEASE

Qianjun Ma, Röel Vrooman, Vanessa Donega, Elly M. Hol

DISSECTING MICROGLIA-ASTROCYTE CROSSTALK AND CCL2-MEDIATED NEURONAL VULNERABILITY IN PARKINSON’S DISEASE USING IPSC-DERIVED MODELS

Jara Montero Muñoz, Veronica Testa, Valentina Baruffi, Styliani Stavroulaki, Marta Puppo, Eshani Chandnani, Loris Mularoni, Yvonne Richaud, Christin Weissleder, Michela Deleidi, Stefano Pluchino, Angel Raya, Antonella Consiglio

CHARACTERIZATION OF NOGO-A–MEDIATED MECHANISMS UNDERLYING DOPAMINERGIC AND MITOCHONDRIAL DYSREGULATION IN AN IPSC-DERIVED PARKINSON’S DISEASE MODEL

Sara Alonso Jiménez, Rouaa Ben Chaabene, Angélique Ducray, Meike Mevissen

MODELING GENETIC HETEROGENEITY IN PARKINSON’S DISEASE USING PATIENT-DERIVED DOPAMINERGIC NEURONS AND MULTI-OMICS APPROACHES

Federica Carrillo, Giorgio Fortunato, Arianna Coppola, Marco Ghirimoldi, Nwife Getrude Okechukwu, Vittoria Federica Borrini, Shahzaib Khoso, Antonietta Di Lorenzo, Mariarca Marciano, Giuseppe Giurin, Francesca D’amato, Cristina D’Aniello, Alessandro Fiorenzano, Teresa Nutile, Danilo Licastro, Sara Pietracupa, Nicola Modugno, Katiuscia Martinello, Sergio Fucile, Marcello Manfredi, Annalisa Fico, Teresa Esposito

HUMAN MIDBRAIN ORGANOIDS REVEAL THE CHARACTERISTICS OF AXONAL MITOCHONDRIA SPECIFIC TO DOPAMINERGIC NEURONS

Masato Koike, Akihiko Nishijima, Soichiro Kakuta, Akihiro Yamaguchi, Kei-ichi Ishikawa, Hideyuki Okano, Wado Akamatsu, Nobutaka Hattori, Mutsumi Yokota

PD MODEL USING IPSC-DERIVED AGED ASTROCYTES REVEALS INDUCTION OF NEUROTOXICITY BY STIMULATION WITH Α-SYNUCLEIN AND IFN-Γ

Hayato Kobayashi, Takashi Wakui, Hiroshi Kato, Setsu Endoh-Yamagami

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.